Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Short-term Investments (2022 - 2025)

Jin Medical International's Short-term Investments history spans 3 years, with the latest figure at $22.2 million for Q3 2025.

  • For Q3 2025, Short-term Investments rose 19.05% year-over-year to $22.2 million; the TTM value through Sep 2025 reached $22.2 million, up 19.05%, while the annual FY2025 figure was $22.2 million, 19.05% up from the prior year.
  • Short-term Investments for Q3 2025 was $22.2 million at Jin Medical International, up from $18.6 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $22.2 million in Q3 2025 and bottomed at $9.8 million in Q3 2023.
  • The 3-year median for Short-term Investments is $18.6 million (2024), against an average of $16.9 million.
  • The largest annual shift saw Short-term Investments skyrocketed 90.62% in 2024 before it rose 19.05% in 2025.
  • A 3-year view of Short-term Investments shows it stood at $9.8 million in 2023, then surged by 90.62% to $18.6 million in 2024, then grew by 19.05% to $22.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Short-term Investments are $22.2 million (Q3 2025), $18.6 million (Q3 2024), and $9.8 million (Q3 2023).